ERBB2 and gastric cancer: Apart from the heterogeneous expression of HER2 in gastric cancer that requires multiple biopsies from different tumor locations, neither tumor heterogeneity nor plasticity are currently embedded in routine diagnostic or therapeutic concepts for digestive cancers.